Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V C Yang

Showing results (11-20 of 94) with videos related to

Pageof 10
Sort By:
Biotechnology and Bioengineering|August 5, 1987
Immobilized heparinase: In vitro reactor modelH Bernstein, V C Yang, R Langer
Annals of the New York Academy of Sciences|January 1, 1988
Heparinase immobilization. Characterization and optimizationV C Yang, H Bernstein, R Langer
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 22, 1999
A recombinant prodrug type approach for triggered delivery of streptokinaseH Wang, H Song, V C Yang
Biotechnology and Bioengineering|August 5, 1987
Distribution of heparinase covalently immobilized to agarose: Experimental and theoretical studiesH Bernstein, V C Yang, R Langer
Applied Biochemistry and Biotechnology|September 1, 1987
An investigation of heparinase immobilizationH Bernstein, V C Yang, R Langer
Thrombosis Research|March 10, 2000
The potential mechanism for the effect of heparin on tissue plasminogen activator-mediated plasminogen activationJ F Liang, Y Li, V C Yang
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|December 8, 2000
A prodrug approach for delivery of t-PA: construction of the cationic t-PA prodrug by a recombinant method and preliminary in vitro evaluation of the constructH Song, J F Liang, V C Yang
Thrombosis Research|April 23, 1999
Low molecular weight protamine: a potential nontoxic heparin antagonistY Byun, V K Singh, V C Yang
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|November 6, 1998
Novel approach for optimizing the capacity and efficacy of a protamine filter for clinical extracorporeal heparin removalY Zhang, V K Singh, V C Yang
International Journal of Pharmaceutics|April 17, 1999
Modified polypeptides containing gamma-benzyl glutamic acid as drug delivery platformsP Markland, G L Amidon, V C Yang
Pageof 10

Showing results (11-20 of 94) with videos related to

Sort By:
Pageof 10
Biotechnology and Bioengineering|August 5, 1987
Immobilized heparinase: In vitro reactor modelH Bernstein, V C Yang, R Langer
Annals of the New York Academy of Sciences|January 1, 1988
Heparinase immobilization. Characterization and optimizationV C Yang, H Bernstein, R Langer
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 22, 1999
A recombinant prodrug type approach for triggered delivery of streptokinaseH Wang, H Song, V C Yang
Biotechnology and Bioengineering|August 5, 1987
Distribution of heparinase covalently immobilized to agarose: Experimental and theoretical studiesH Bernstein, V C Yang, R Langer
Applied Biochemistry and Biotechnology|September 1, 1987
An investigation of heparinase immobilizationH Bernstein, V C Yang, R Langer
Thrombosis Research|March 10, 2000
The potential mechanism for the effect of heparin on tissue plasminogen activator-mediated plasminogen activationJ F Liang, Y Li, V C Yang
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|December 8, 2000
A prodrug approach for delivery of t-PA: construction of the cationic t-PA prodrug by a recombinant method and preliminary in vitro evaluation of the constructH Song, J F Liang, V C Yang
Thrombosis Research|April 23, 1999
Low molecular weight protamine: a potential nontoxic heparin antagonistY Byun, V K Singh, V C Yang
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|November 6, 1998
Novel approach for optimizing the capacity and efficacy of a protamine filter for clinical extracorporeal heparin removalY Zhang, V K Singh, V C Yang
International Journal of Pharmaceutics|April 17, 1999
Modified polypeptides containing gamma-benzyl glutamic acid as drug delivery platformsP Markland, G L Amidon, V C Yang
Pageof 10